Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mistry

Showing results (131-140 of 271) with videos related to

Pageof 28
Sort By:
Cancer Research|February 24, 2001
In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576P Mistry, A J Stewart, W Dangerfield, et al.
British Journal of Cancer|April 17, 1999
In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistanceP Mistry, J Plumb, S Eccles, et al.
The Journal of the Association of Physicians of India|November 1, 1979
Electrical aversion therapy of chronic alcoholismV N Bagadia, V K Mundra, J H Gopalani, et al.
Free Radical Research|February 24, 2001
Development of a quality control material for the measurement of 8-oxo-7,8-dihydro-2'-deoxyguanosine, an in vivo marker of oxidative stress, and comparison of results from different laboratoriesJ Lunec, K E Herbert, Jones GDD, et al.
International Journal of Colorectal Disease|November 19, 2020
Comparison of clinical and paraclinical characteristics of patients with urge, mixed, and passive fecal incontinence: a systematic literature reviewCharlotte Desprez, N Turmel, C Chesnel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Biotransformation of the platinum drug JM216 following oral administration to cancer patientsF I Raynaud, P Mistry, A Donaghue, et al.
Journal of Chromatography. A|September 29, 1995
Metabolic studies of an orally active platinum anticancer drug by liquid chromatography-electrospray ionization mass spectrometryG K Poon, F I Raynaud, P Mistry, et al.
Anti-Cancer Drugs|May 4, 2001
Antitumor activity of XR5944, a novel and potent topoisomerase poisonA J Stewart, P Mistry, W Dangerfield, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administrationM J McKeage, P Mistry, J Ward, et al.
The Annals of Thoracic Surgery|October 28, 2021
Enhancing Recovery in Congenital Cardiac SurgeryNathalie Roy, M Fernanda Parra, Morgan L Brown, et al.
Pageof 28

Showing results (131-140 of 271) with videos related to

Sort By:
Pageof 28
Cancer Research|February 24, 2001
In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576P Mistry, A J Stewart, W Dangerfield, et al.
British Journal of Cancer|April 17, 1999
In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistanceP Mistry, J Plumb, S Eccles, et al.
The Journal of the Association of Physicians of India|November 1, 1979
Electrical aversion therapy of chronic alcoholismV N Bagadia, V K Mundra, J H Gopalani, et al.
Free Radical Research|February 24, 2001
Development of a quality control material for the measurement of 8-oxo-7,8-dihydro-2'-deoxyguanosine, an in vivo marker of oxidative stress, and comparison of results from different laboratoriesJ Lunec, K E Herbert, Jones GDD, et al.
International Journal of Colorectal Disease|November 19, 2020
Comparison of clinical and paraclinical characteristics of patients with urge, mixed, and passive fecal incontinence: a systematic literature reviewCharlotte Desprez, N Turmel, C Chesnel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Biotransformation of the platinum drug JM216 following oral administration to cancer patientsF I Raynaud, P Mistry, A Donaghue, et al.
Journal of Chromatography. A|September 29, 1995
Metabolic studies of an orally active platinum anticancer drug by liquid chromatography-electrospray ionization mass spectrometryG K Poon, F I Raynaud, P Mistry, et al.
Anti-Cancer Drugs|May 4, 2001
Antitumor activity of XR5944, a novel and potent topoisomerase poisonA J Stewart, P Mistry, W Dangerfield, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administrationM J McKeage, P Mistry, J Ward, et al.
The Annals of Thoracic Surgery|October 28, 2021
Enhancing Recovery in Congenital Cardiac SurgeryNathalie Roy, M Fernanda Parra, Morgan L Brown, et al.
Pageof 28